文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Masaya Watanabe
发表
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design
K. Kario, N. Kitamura, Y. Nakajima, 2020, Diabetes Therapy.